Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Torii Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, specializing in the development and commercialization of drugs in the fields of renal disease, hemodialysis, skin disease, and allergens. As a subsidiary of Japan Tobacco Inc. (JT), Torii leverages a strong partnership for R&D while maintaining its own manufacturing and sales infrastructure. The company is particularly well-known for its allergen immunotherapy products and its portfolio of treatments for atopic dermatitis and pruritus. Torii's business model focuses on the Japanese domestic market, often in-licensing global compounds for local development and distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Japan Niao Ju Pharmaceutical.